Dallas, TX -- (SBWire) -- 10/03/2014 --MarketOptimizer.org adds “Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014” report to its research database.

New clinical trial report, “Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014? provides data on the Hypertropic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypertropic Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypertropic Cardiomyopathy.

Complete Report Details @ http://www.marketoptimizer.org/hypertropic-cardiomyopathy-global-clinical-trials-review-h2-2014.html .

Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Order a Purchase copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10702 .

Table of Contents
Table of Contents 2
List of Tables3
List of Figures 4
Introduction 5
Hypertropic Cardiomyopathy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Hypertropic Cardiomyopathy to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Hypertropic Cardiomyopathy 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Hypertropic Cardiomyopathy Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Gilead Sciences, Inc. 26
Clinical Trial Overview of Gilead Sciences, Inc. 26
Novartis AG 27
Clinical Trial Overview of Novartis AG 27
Heart Metabolics Ltd. 28
Clinical Trial Overview of Heart Metabolics Ltd. 28
A. Menarini Industrie Farmaceutiche Riunite Srl 29
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 29
Clinical Trial Overview of Top Institutes / Government 30
National Heart, Lung, and Blood Institute 30
Clinical Trial Overview of National Heart, Lung, and Blood Institute 30
Johns Hopkins University 31
Clinical Trial Overview of Johns Hopkins University 31
University of Miami 32
Clinical Trial Overview of University of Miami 32
Brigham and Women’s Hospital 33
Clinical Trial Overview of Brigham and Women’s Hospital 33
Stanford University 34
Clinical Trial Overview of Stanford University 34
University of Calgary 35
Clinical Trial Overview of University of Calgary 35
Johann Wolfgang Goethe University Hospitals 36
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 36
Massachusetts General Hospital 37
Clinical Trial Overview of Massachusetts General Hospital 37
Duke University 38
Clinical Trial Overview of Duke University 38
Assistance Publique – Hopitaux de Paris 39
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 39
Five Key Clinical Profiles 40
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

Browse more reports on Pharmaceuticals Market @ http://www.marketoptimizer.org/category/life-sciences/pharmaceuticals .